NFKB1 and neoplasm: Our finding that elevated MLR (>0.26) independently predicts recurrence (HR=1.66) suggests monocyte-dominated inflammation may trigger NF-κB-mediated epithelial-mesenchymal transition (EMT) and circulating tumor cell (CTC) dissemination, driving early relapse (29, 37).